Identification of compounds that bind mitochondrial F1F0 ATPase by screening a triazine library for correction of albinism.

A triazine-based combinatorial library of small molecules was screened in albino murine melanocytes to identify compounds that induce pigmentation. Six compounds (of 1536 screened) produced at least 3-fold increases in pigmentation. Immunohistochemical studies demonstrated that the compounds conferred correct routing of the mistrafficked enzyme tyrosinase, which is critical to normal melanogenesis. Affinity matrices of the immobilized compounds allowed the cellular target to be identified as the mitochondrial F1F0-ATP synthase. Oligomycin and aurovertin B, small molecules known to inhibit the mitochondrial ATP synthase, were shown to compete with the triazine-based compounds for their cellular target in albino melanocytes and confer similar effects on pigmentation and tyrosinase rerouting. This is the first demonstration of the mitochondrial ATP synthase as a potential therapeutic target for restoring pigmentation in albino melanocytes.

[1]  P. Schultz,et al.  Purine‐Based Inhibitors of Inositol‐1,4,5‐trisphosphate‐3‐kinase , 2002, Chembiochem : a European journal of chemical biology.

[2]  S. Schreiber.  Chemical genetics resulting from a passion for synthetic organic chemistry. , 1998, Bioorganic & medicinal chemistry.

[3]  S. Orlow,et al.  Correction of defective early tyrosinase processing by bafilomycin A1 and monensin in pink-eyed dilution melanocytes. , 2004, Pigment cell research.

[4]  P. Schultz,et al.  Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors. , 1999, Chemistry & biology.

[5]  R. Lewis,et al.  Brown Ocuuiocutaneous Albinism: Clinical, Ophthalmological, and Biochemical Characterization , 1985 .

[6]  Seth J Orlow,et al.  Pink-eyed dilution protein controls the processing of tyrosinase. , 2002, Molecular biology of the cell.

[7]  G. Spalluto,et al.  7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility. , 2002, Journal of medicinal chemistry.

[8]  K. Altendorf,et al.  Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. , 1997, The Journal of experimental biology.

[9]  R. Spritz,et al.  A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism , 1993, Nature.

[10]  V. Ferrans,et al.  The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase. , 2002, Pigment cell research.

[11]  E. Berger,et al.  Golgi-disturbing agents , 1998, Histochemistry and Cell Biology.

[12]  R. Halaban,et al.  Abnormal Acidification of Melanoma Cells Induces Tyrosinase Retention in the Early Secretory Pathway* , 2002, The Journal of Biological Chemistry.

[13]  Nicholas J Westwood,et al.  Using small molecules to study big questions in cellular microbiology , 2002, Cellular microbiology.

[14]  M. Hoogduijn,et al.  Melanosomal pH, pink locus protein and their roles in melanogenesis. , 2001, The Journal of investigative dermatology.

[15]  N. Gray.  Combinatorial libraries and biological discovery , 2001, Current Opinion in Neurobiology.

[16]  R Scott Lokey,et al.  Forward chemical genetics: progress and obstacles on the path to a new pharmacopoeia. , 2003, Current opinion in chemical biology.

[17]  G. Fassina,et al.  Combinatorial Chemistry and Technology: Principles, Methods and Applications , 1999 .

[18]  R. Spritz,et al.  Complementation of hypopigmentation in p-mutant (pink-eyed dilution) mouse melanocytes by normal human P cDNA, and defective complementation by OCA2 mutant sequences. , 1997, The Journal of investigative dermatology.

[19]  Stuart L. Schreiber,et al.  The small-molecule approach to biology , 2003 .

[20]  S. Orlow,et al.  Mislocalization of melanosomal proteins in melanocytes from mice with oculocutaneous albinism type 2. , 2001, Experimental eye research.

[21]  Pierfausto Seneci,et al.  Solid-Phase Synthesis and Combinatorial Technologies , 2000 .

[22]  J. Abrahams,et al.  The structure of bovine F1-ATPase complexed with the antibiotic inhibitor aurovertin B. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Orlow,et al.  Intracellular Distribution and Late Endosomal Effects of the Ocular Albinism Type 1 Gene Product: Consequences of Disease‐Causing Mutations and Implications for Melanosome Biogenesis , 2001, Traffic.

[24]  A. Gangjee,et al.  Design, synthesis, and biological activities of classical N-[4-[2-(2-amino-4-ethylpyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid and its 6-methyl derivative as potential dual inhibitors of thymidylate synthase and dihydrofolate reductase and as potential antitumor agents. , 2003, Journal of Medicinal Chemistry.

[25]  Young-Tae Chang,et al.  Tagged library approach to chemical genomics and proteomics. , 2004, Current opinion in chemical biology.

[26]  N S Gray,et al.  Discovery of estrogen sulfotransferase inhibitors from a purine library screen. , 2001, Journal of medicinal chemistry.

[27]  Derek S. Tan.  Sweet surrender to chemical genetics , 2002, Nature Biotechnology.

[28]  Tae-Wook Kang,et al.  Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening. , 2003, Journal of the American Chemical Society.